Emergo Therapeutics Patents – Insights & Stats (Updated 2024)

Emergo Therapeutics has a total of 29 patents globally, out of which 7 have been granted. Of these 29 patents, more than 75% patents are active. The United States of America is where Emergo Therapeutics has filed the maximum number of patents, followed by Europe (EPO), Australia, Canada and Japan. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Emergo Therapeutics.

Emergo Therapeutics was founded in 2017. Emergo Therapeutics, is a medicine company, creates treatments to ease symptoms of flu and similar illnesses.

Do read about some of the most popular patents of Emergo Therapeutics which have been covered by us in this article and also you can find Emergo Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Emergo Therapeutics patent portfolio.

How many patents does Emergo Therapeutics have?

Emergo Therapeutics has a total of 29 patents globally. These patents belong to 3 unique patent families. Out of 29 patents, 22 patents are active.

How Many Patents did Emergo Therapeutics File Every Year?

Emergo Therapeutics Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantEmergo Therapeutics Applications FiledEmergo Therapeutics Patents Granted
20231
20222
20212
20201
201962
201811
201720

How many Emergo Therapeutics patents are Alive/Dead?

Worldwide Patents

Emergo Therapeutics Patent Portfolio

How Many Patents did Emergo Therapeutics File in Different Countries?

Emergo Therapeutics Worldwide Patent Filing

Countries in which Emergo Therapeutics Filed Patents

CountryPatent
United States Of America5
Europe (EPO)2
Australia2
Canada2
Japan2
Philippines1
South Africa1
Saudi Arabia1
India1
Brazil1
Indonesia1
Russia1
Israel1
Singapore1
China1
South Korea1
Malaysia1
Hong Kong (S.A.R.)1
Mexico1

Where are Research Centers of Emergo Therapeutics Patents Located?

R&D Centres of Emergo Therapeutics

What Percentage of Emergo Therapeutics US Patent Applications Were Granted?

Emergo Therapeutics (Excluding its subsidiaries) has filed 2 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 2 have been granted leading to a grant rate of 100%.

Below are the key stats of Emergo Therapeutics patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Emergo Therapeutics?

Law FirmTotal ApplicationsSuccess Rate
Myers Bigel PA2100%

List of Emergo Therapeutics patents

Emergo Therapeutics PatentsTitle
US11478463B2Mast Cell Stabilizers For Treatment Of Chronic Inflammatory Conditions
US11072648B2Mast Cell Stabilizers For Treatment Of Fever
US10501527B2Mast Cell Stabilizers For Treatment Of Hypercytokinemia And Viral Infection
US10494420B2Mast Cell Stabilizers For Treatment Of Hypercytokinemia And Viral Infection
US10160796B2Mast Cell Stabilizers For Treatment Of Hypercytokinemia And Viral Infection
EP3528809A4Mast Cell Stabilizers For Treatment Of Chronic Inflammatory Conditions
EP3509596A4Mast Cell Stabilizers For Treatment Of Hypercytokinemia And Viral Infection
CN109952101AMast Cell Stabilizers For Treatment Of Hypercytokinemia And Viral Infection
AU2023204000A1Mast Cell Stabilizers For Treatment Of Hypercytokinemia And Viral Infection
CA3040420A1Mast Cell Stabilizers For Treatment Of Chronic Inflammatory Conditions
CA3036230A1Mast Cell Stabilizers For Treatment Of Hypercytokinemia And Viral Infection
MX389999BMast Cell Stabilizers For The Treatment Of Hypercytokinemia And Viral Infection
RU2760682C2Mast Cell Stabilizers For The Treatment Of Hypercytokinemia And Viral Infection
SA519401254AMast Cell Stabilizers For The Treatment Of Cytokine Hyperemia And Viral Infection
HK40011695AMast Cell Stabilizers For Treatment Of Hypercytokinemia And Viral Infection
ID201906535AMast Cell Stabilizers For The Treatment Of Hypercytokinemia And Virus Infections
IL265208A0Mast Cell Stabilizers For Treatment Of Hypercytokinemia And Viral Infection
BR112019004496A2Mast Cell Stabilizers For The Treatment Of Hypercytokinemia And Viral Infection
PH12019500513A1Mast Cell Stabilizers For Treatment Of Hypercytokinemia And Viral Infection
SG11201902056PAMast Cell Stabilizers For Treatment Of Hypercytokinemia And Viral Infection
ZA201901633AMast Cell Stabilizers For Treatment Of Hypercytokinemia And Viral Infection
MYPI2019000588A0Mast Cell Stabilizers For Treatment Of Hypercytokinemia And Viral Infection
JP2019533018A5Mast Cell Stabilizers For The Treatment Of Chronic Inflammatory Conditions
JP2019529541A5Mast Cell Stabilizers For The Treatment Of Hypercytokinemia And Viral Infections
AU2017325010A1Mast Cell Stabilizers For Treatment Of Hypercytokinemia And Viral Infection
WO2018075574A1Mast Cell Stabilizers For Treatment Of Chronic Inflammatory Conditions
WO2018048989A1Mast Cell Stabilizers For Treatment Of Hypercytokinemia And Viral Infection
KR1020190073365AMast Cell Stabilizers For The Treatment Of Cytokine Hypersecretion And Viral Infections
IN201917010051AMast Cell Stabilizers For Treatment Of Hypercytokinemia And Viral Infection

What are Emergo Therapeutics key innovation segments?

What Technologies are Covered by Emergo Therapeutics?

The chart below distributes patents filed by Emergo Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Emergo Therapeutics thinks it’s important to protect particular technology inventions.

R&D Focus: How has Emergo Therapeutics search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Emergo Therapeutics?

Related Articles

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.